Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

An agent-based model of the prostate tumor microenvironment simulated how androgen deprivation therapy influences cell interactions, suggesting resistance arises in clustered cells and that therapy may enhance tumor survival through macrophage immunomodulation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

The paper studies how androgen deprivation therapy (ADT) alters interactions among prostate cancer (PCa) cells, fibroblasts, and polarized macrophages in the tumor microenvironment, using a PCa-specific agent-based model built from in vitro cell proliferation data. The model represents PCa cells, fibroblasts, and “pro-inflammatory” M1-like and “pro-tumor” M2-like macrophages as agents under a validated set of base assumptions, and it simulates ADT-induced hormonal perturbations on these interacting cell populations. Key findings are that ADT-consistent growth patterns emerge that mimic human PCa, including clustered emergence of resistant cells for CRPC and a role for fibroblasts in both competing for space and creating tumor-proliferative niches, alongside predicted ADT-driven immunomodulatory effects on macrophages that could enhance tumor survival. A major limitation stated is that the modeling relies on the simple validated assumptions and in vitro-derived proliferation data rather than direct patient-calibrated dynamics. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Inhibiting androgen receptor (AR) signaling through androgen deprivation therapy (ADT) reduces prostate cancer (PCa) growth in virtually all patients, but response is temporary, and resistance inevitably develops, ultimately leading to lethal castration-resistant prostate cancer (CRPC). The tumor microenvironment (TME) plays an important role in the development and progression of PCa. In addition to tumor cells, TME-resident macrophages and fibroblasts express AR and are therefore also affected by ADT. However, the interplay of different TME cell types in the development of CRPC remains largely unexplored. To understand the complex stochastic nature of cell-cell interactions, we created a PCa-specific agent-based model (PCABM) based on in vitro cell proliferation data. PCa cells, fibroblasts, “pro-inflammatory” M1-like and “pro-tumor” M2-like polarized macrophages are modeled as agents from a simple set of validated base assumptions. PCABM allows us to simulate the effect of ADT on the interplay between various prostate TME cell types. The resulting in vitro growth patterns mimic human PCa. Our PCABM can effectively model hormonal perturbations by ADT, in which PCABM suggests that CRPC arises in clusters of resistant cells, as is observed in multifocal PCa. In addition, fibroblasts compete for cellular space in the TME while simultaneously creating niches for tumor cells to proliferate in. Finally, PCABM predicts that ADT has immunomodulatory effects on macrophages that may enhance tumor survival. Taken together, these results suggest that AR plays a critical role in the cellular interplay and stochastic interactions in the TME that influence tumor cell behavior and CRPC development.
Full text 17,222 characters · extracted from preprint-html · click to expand
Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties Federica Eduati, Maisa van Genderen, Jeroen Kneppers, Anniek Zaalberg, and 3 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3265572/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 21 Feb, 2024 Read the published version in npj Systems Biology and Applications → Version 1 posted 11 You are reading this latest preprint version Abstract Inhibiting androgen receptor (AR) signaling through androgen deprivation therapy (ADT) reduces prostate cancer (PCa) growth in virtually all patients, but response is temporary, and resistance inevitably develops, ultimately leading to lethal castration-resistant prostate cancer (CRPC). The tumor microenvironment (TME) plays an important role in the development and progression of PCa. In addition to tumor cells, TME-resident macrophages and fibroblasts express AR and are therefore also affected by ADT. However, the interplay of different TME cell types in the development of CRPC remains largely unexplored. To understand the complex stochastic nature of cell-cell interactions, we created a PCa-specific agent-based model (PCABM) based on in vitro cell proliferation data. PCa cells, fibroblasts, “pro-inflammatory” M1-like and “pro-tumor” M2-like polarized macrophages are modeled as agents from a simple set of validated base assumptions. PCABM allows us to simulate the effect of ADT on the interplay between various prostate TME cell types. The resulting in vitro growth patterns mimic human PCa. Our PCABM can effectively model hormonal perturbations by ADT, in which PCABM suggests that CRPC arises in clusters of resistant cells, as is observed in multifocal PCa. In addition, fibroblasts compete for cellular space in the TME while simultaneously creating niches for tumor cells to proliferate in. Finally, PCABM predicts that ADT has immunomodulatory effects on macrophages that may enhance tumor survival. Taken together, these results suggest that AR plays a critical role in the cellular interplay and stochastic interactions in the TME that influence tumor cell behavior and CRPC development. Biological sciences/Cancer Biological sciences/Systems biology Health sciences/Oncology agent-based modeling androgen receptor tumor microenvironment androgen deprivation therapy castration resistance Full Text Additional Declarations (Not answered) Supplementary Files vanGenderenatalSupplfigs.pdf vanGenderenatalSuppltable1.xlsx vanGenderenatalSuppltable2.xlsx Cite Share Download PDF Status: Published Journal Publication published 21 Feb, 2024 Read the published version in npj Systems Biology and Applications → Version 1 posted Editorial decision: revise 11 Sep, 2023 Review # 3 received at journal 08 Sep, 2023 Reviewer # 3 agreed at journal 08 Sep, 2023 Review # 2 received at journal 08 Sep, 2023 Reviewer # 2 agreed at journal 08 Sep, 2023 Review # 1 received at journal 28 Aug, 2023 Reviewer # 1 agreed at journal 28 Aug, 2023 Reviewers invited by journal 23 Aug, 2023 Submission checks completed at journal 16 Aug, 2023 Editor assigned by journal 15 Aug, 2023 First submitted to journal 15 Aug, 2023 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3265572","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":229405171,"identity":"0896bde2-e14a-41ac-9154-be279bf3d7c6","order_by":0,"name":"Federica Eduati","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAtElEQVRIiWNgGAWjYBAC9gYGBgkgzcMP4VsQ1sJzAKzFgEeyDcyXIF4Lg8ExorUwMB+8zVPzR8b4fo/hA8YdRGlhS7bmOWbAY3aMx9iA8QwRWuwZeMykedjAWswkGNuIsoX/mzTPPwMe4zYe8x9EauFhk+ZtM+AxYOMxYyBOCzObseXcPmMeiWNpxRKJRGlhb3544803OXv+5sMbP3xssyGshYEZmZNAhIZRMApGwSgYBUQAAOL9KBtOOZICAAAAAElFTkSuQmCC","orcid":"https://orcid.org/0000-0002-7822-3867","institution":"Eindhoven University of Technology","correspondingAuthor":true,"prefix":"","firstName":"Federica","middleName":"","lastName":"Eduati","suffix":""},{"id":229405172,"identity":"e40f4b78-624c-4bd5-a797-d3a6457cb40d","order_by":1,"name":"Maisa van Genderen","email":"","orcid":"https://orcid.org/0000-0002-7394-9888","institution":"Amsterdam UMC - Location VUmc","correspondingAuthor":false,"prefix":"","firstName":"Maisa","middleName":"van","lastName":"Genderen","suffix":""},{"id":229405173,"identity":"a8f25263-4e8a-42f3-9c93-e1394317dfe2","order_by":2,"name":"Jeroen Kneppers","email":"","orcid":"","institution":"The Netherlands Cancer Institue","correspondingAuthor":false,"prefix":"","firstName":"Jeroen","middleName":"","lastName":"Kneppers","suffix":""},{"id":229405174,"identity":"f740f68e-1e6e-4e05-b7e9-9b0fe82cac38","order_by":3,"name":"Anniek Zaalberg","email":"","orcid":"","institution":"The Netherlands Cancer Institue","correspondingAuthor":false,"prefix":"","firstName":"Anniek","middleName":"","lastName":"Zaalberg","suffix":""},{"id":229405175,"identity":"e572a816-61dc-4d49-991e-f226d3cae5d6","order_by":4,"name":"Elise Bekers","email":"","orcid":"","institution":"The Netherlands Cancer Institue","correspondingAuthor":false,"prefix":"","firstName":"Elise","middleName":"","lastName":"Bekers","suffix":""},{"id":229405176,"identity":"0f87967c-3c7f-462c-8ad1-95300ad31e77","order_by":5,"name":"Andries Bergman","email":"","orcid":"","institution":"The Netherlands Cancer Institue","correspondingAuthor":false,"prefix":"","firstName":"Andries","middleName":"","lastName":"Bergman","suffix":""},{"id":229405177,"identity":"9b83081c-6b66-40f7-b2fe-27ddc8884ae5","order_by":6,"name":"Wilbert Zwart","email":"","orcid":"","institution":"The Netherlands Cancer Institue","correspondingAuthor":false,"prefix":"","firstName":"Wilbert","middleName":"","lastName":"Zwart","suffix":""}],"badges":[],"createdAt":"2023-08-15 11:01:17","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3265572/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3265572/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41540-024-00344-6","type":"published","date":"2024-02-21T05:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":51471687,"identity":"bcb93fc6-4597-463c-acbb-662212ac36c8","added_by":"auto","created_at":"2024-02-22 08:12:15","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1091977,"visible":true,"origin":"","legend":"","description":"","filename":"vanGenderenetalmanuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3265572/v1_covered_3c58181a-fb49-45fc-a77e-260546db60aa.pdf"},{"id":42408451,"identity":"3008e892-46c8-4403-92c9-adb6b849b9ce","added_by":"auto","created_at":"2023-08-31 07:31:16","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":6575943,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cbr\u003e\u003c/p\u003e","description":"","filename":"vanGenderenatalSupplfigs.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3265572/v1/373da3ce6244062e0510354c.pdf"},{"id":42408449,"identity":"08b22884-525f-405b-b344-0cb3b62b2119","added_by":"auto","created_at":"2023-08-31 07:31:16","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":11893,"visible":true,"origin":"","legend":"","description":"","filename":"vanGenderenatalSuppltable1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-3265572/v1/149bdf6ff142bd5c0daee252.xlsx"},{"id":42408450,"identity":"07574d6c-a882-4608-9043-89cfa1a71abe","added_by":"auto","created_at":"2023-08-31 07:31:16","extension":"xlsx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":9155,"visible":true,"origin":"","legend":"","description":"","filename":"vanGenderenatalSuppltable2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-3265572/v1/fa50617db07bb06ebf06c4d1.xlsx"}],"financialInterests":"(Not answered)","formattedTitle":"Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"npj-systems-biology-and-applications","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"npjsba","sideBox":"Learn more about [npj Systems Biology and Applications](http://www.nature.com/npjsba/)","snPcode":"41540","submissionUrl":"https://submission.springernature.com/new-submission/41540/3","title":"npj Systems Biology and Applications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"NPJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"agent-based modeling, androgen receptor, tumor microenvironment, androgen deprivation therapy, castration resistance","lastPublishedDoi":"10.21203/rs.3.rs-3265572/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3265572/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eInhibiting androgen receptor (AR) signaling through androgen deprivation therapy (ADT) reduces prostate cancer (PCa) growth in virtually all patients, but response is temporary, and resistance inevitably develops, ultimately leading to lethal castration-resistant prostate cancer (CRPC). The tumor microenvironment (TME) plays an important role in the development and progression of PCa. In addition to tumor cells, TME-resident macrophages and fibroblasts express AR and are therefore also affected by ADT. However, the interplay of different TME cell types in the development of CRPC remains largely unexplored.\u003c/p\u003e\n\u003cp\u003eTo understand the complex stochastic nature of cell-cell interactions, we created a PCa-specific agent-based model (PCABM) based on in vitro cell proliferation data. PCa cells, fibroblasts, “pro-inflammatory” M1-like and “pro-tumor” M2-like polarized macrophages are modeled as agents from a simple set of validated base assumptions. PCABM allows us to simulate the effect of ADT on the interplay between various prostate TME cell types. The resulting in vitro growth patterns mimic human PCa.\u003c/p\u003e\n\u003cp\u003eOur PCABM can effectively model hormonal perturbations by ADT, in which PCABM suggests that CRPC arises in clusters of resistant cells, as is observed in multifocal PCa. In addition, fibroblasts compete for cellular space in the TME while simultaneously creating niches for tumor cells to proliferate in. Finally, PCABM predicts that ADT has immunomodulatory effects on macrophages that may enhance tumor survival. Taken together, these results suggest that AR plays a critical role in the cellular interplay and stochastic interactions in the TME that influence tumor cell behavior and CRPC development.\u003c/p\u003e","manuscriptTitle":"Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2023-08-31 07:31:11","doi":"10.21203/rs.3.rs-3265572/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"revise","date":"2023-09-11T05:22:49+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"This content is not available.","date":"2023-09-08T19:06:42+00:00","index":3,"fulltext":"This content is not available."},{"type":"reviewerAgreed","content":"This content is not available.","date":"2023-09-08T18:06:42+00:00","index":3,"fulltext":"This content is not available."},{"type":"editorInvitedReview","content":"This content is not available.","date":"2023-09-08T17:43:41+00:00","index":2,"fulltext":"This content is not available."},{"type":"reviewerAgreed","content":"This content is not available.","date":"2023-09-08T16:43:41+00:00","index":2,"fulltext":"This content is not available."},{"type":"editorInvitedReview","content":"This content is not available.","date":"2023-08-28T15:22:12+00:00","index":1,"fulltext":"This content is not available."},{"type":"reviewerAgreed","content":"This content is not available.","date":"2023-08-28T14:22:12+00:00","index":1,"fulltext":"This content is not available."},{"type":"reviewersInvited","content":"","date":"2023-08-23T14:38:26+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2023-08-16T06:57:25+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2023-08-15T10:58:22+00:00","index":"","fulltext":""},{"type":"submitted","content":"npj Systems Biology and Applications","date":"2023-08-15T10:58:21+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"npj-systems-biology-and-applications","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"npjsba","sideBox":"Learn more about [npj Systems Biology and Applications](http://www.nature.com/npjsba/)","snPcode":"41540","submissionUrl":"https://submission.springernature.com/new-submission/41540/3","title":"npj Systems Biology and Applications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"NPJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"6a6590f4-4449-40a9-9755-361348e6164b","owner":[],"postedDate":"August 31st, 2023","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":24312693,"name":"Biological sciences/Cancer"},{"id":24312694,"name":"Biological sciences/Systems biology"},{"id":24312695,"name":"Health sciences/Oncology"}],"tags":[],"updatedAt":"2024-02-22T08:12:05+00:00","versionOfRecord":{"articleIdentity":"rs-3265572","link":"https://doi.org/10.1038/s41540-024-00344-6","journal":{"identity":"npj-systems-biology-and-applications","isVorOnly":false,"title":"npj Systems Biology and Applications"},"publishedOn":"2024-02-21 05:00:00","publishedOnDateReadable":"February 21st, 2024"},"versionCreatedAt":"2023-08-31 07:31:11","video":"","vorDoi":"10.1038/s41540-024-00344-6","vorDoiUrl":"https://doi.org/10.1038/s41540-024-00344-6","workflowStages":[]},"version":"v1","identity":"rs-3265572","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3265572","identity":"rs-3265572","version":["v1"]},"buildId":"_2-kVJe1T_tPrBINL-cwx","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00